VANDERSON GERALDO ROCHA
Projetos de Pesquisa
Unidades Organizacionais
Departamento de Clínica Médica, Faculdade de Medicina - Docente
Instituto Central, Hospital das Clínicas, Faculdade de Medicina
LIM/31 - Laboratório de Genética e Hematologia Molecular, Hospital das Clínicas, Faculdade de Medicina - Líder
Instituto Central, Hospital das Clínicas, Faculdade de Medicina
LIM/31 - Laboratório de Genética e Hematologia Molecular, Hospital das Clínicas, Faculdade de Medicina - Líder
11 resultados
Resultados de Busca
Agora exibindo 1 - 10 de 11
conferenceObject Risk Factors for Early Mortality in Fragile Patients with Non-Hodgkin Lymphoma at Diagnosis Who Need Hospitalization in a Developing Country(2016) BARBOSA, Ivan de Carvalho Valente; BELLESSO, Marcelo; LEVY, Debora; PEREIRA, Juliana; ROCHA, VandersonconferenceObject Impact of Refined Disease Risk Index after Single and Double Umbilical Cord Blood Transplantation in Adults with Hematological Malignancies(2016) PAVIGLIANITI, Annalisa; RUGGERI, Annalisa; SANZ, Guillermo; MILPIED, Noel; BLAISE, Didier; ESQUIROL, Albert; ARCESE, William; FERRA, Christelle; IFRAH, Norbert; BOURIS, Jean Henri; RAJ, Kavita; VEELKEN, Joan Hendrik; SICA, Simona; CONTENTIN, Nathalie; BLOOR, Adrian; VOLT, Fernanda; KENZEY, Chantal; ROCHA, Vanderson; GLUCKMAN, Eliane- Umbilical cord blood cells from unrelated donor as an alternative source of hematopoietic stem cells for transplantation in children and adults(2016) ROCHA, VandersonUmbilical cord blood (CB) is an alternative source of hematopoietic stem cells (HSC) for patients requiring allogeneic HSC transplantation but lacking a suitable human leukocyte antigen (HLA)-matched donor. Using CB has many advantages, including lower HLA-matching requirements, increased donor availability, and low rates of graft-versus-host disease. Furthermore, with over 630,000 cryopreserved volunteer CB units currently stored in international CB banks worldwide, CB is rapidly available for those patients requiring urgent transplantation. However, concern remains over the low HSC doses available in CB grafts, resulting in delayed engraftment and poor immune reconstitution. This article reviews the current use and future developments of unrelated allogeneic CB transplantation (CBT). An overview of the encouraging results of CBT and the comparisons with other HSC sources and transplant strategies both in children and adults with malignant and non-malignant diseases are shown. We will discuss important factors that need to be considered when selecting CB units for transplantation to further improve the results of CBT.
bookPart Abordagem das imunodeficiências primárias e suas necessidades em UTI(2016) FERNANDES, Juliana Folloni; ROCHA, Vanderson; NUDELMAN, VictorconferenceObject Development of a Risk Score for Prediction of Overall Survival Following Umbilical Cord Blood Transplantation in Acute Leukemia Patients: A Study from the Acute Leukemia Working Party (WP) and Paediatric Disease WP of the European Society for Blood and Marrow Transplantation (EBMT), and Eurocord(2016) SHOUVAL, Roni; RUGGERI, Annalisa; LABOPIN, Myriam; MOHTY, Mohamad; SANZ, Guillermo; MICHEL, Gerard; PETERSEN, Eefke; CHEVALLIER, Patrice; AL-SERAIHY, Amal; MILPIED, Noel-Jean; RUBIO, Cristina Diaz de Heredia; ARCESE, William; BLAISE, Didier; ROCHA, Vanderson; FEIN, Joshua; UNGER, Ron; BARON, Frederic; BADER, Peter; GLUCKMAN, Eliane; NAGLER, ArnonconferenceObject Outcomes and Impact of Donor Lymphocyte Infusion after Reduced Intensity Conditioned-Alemtuzumab Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Mature Lymphoid Malignancies(2016) BRIERLEY, Charlotte K.; JONES, Francesca M.; HANLON, Katherine; PENIKET, Andrew; MEDD, Patrick; CLARK, Andrew; PARKER, Anne; CHAGANTI, Sridhar; MALLADI, Ram; CRADDOCK, Charles; DANBY, Robert; ROCHA, VandersonconferenceObject Chronic Graft-Versus-Host Disease in Double Cord Blood Transplantation According to National Institutes of Health 2005 Criteria: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party of the EBMT(2016) HAYASHI, Hiromi; RUGGERI, Annalisa; AYOUBI, Hanadi Rafii -El; CORNELISSEN, Jan J.; SOCIE, Gerard; ANDERSEN, Niels S.; MICHALLET, Mauricette; KARAKASIS, Dimitrios; PETERSEN, Eefke; VEELKEN, Joan Hendrik; CAHN, Jean Yves; ROHRLICH, Pierre-Simon; MERCIER, Melanie; VOLT, Fernanda; KENZEY, Chantal; XAVIER, Erick; ROCHA, Vanderson; GLUCKMAN, ElianeconferenceObject How to Monitor Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation: A Survey from the EBMT-Cellular Therapy & Immunobiology Working Party(2016) GRECO, Raffaella; CICERI, Fabio; NOVIELLO, Maddalena; BONDANZA, Attilio; VAGO, Luca; OLIVEIRA, Giacomo; PECCATORI, Jacopo; CIERI, Nicoletta; RUGGERI, Annalisa; KOEHL, Ulrike; FLEISCHHAUER, Katharina; ROCHA, Vanderson; DAZZI, Francesco; WERF, Steffie Maria van der; TERWEL, Sofie Rosanne; TOUBERT, Antoine; CHABANNON, Christian; BONINI, ChiaraconferenceObject Circulating Microparticles As Predictive Biomarkers of Acute Graft Versus Host Disease(2016) CARNEIRO, Thiago Xavier; MARRESE, Daniella Gregolin; SANTOS, Melina Goncalves dos; GONCALVES, Matheus Vescovi; NOVIS, Yana Sarkis; RIZZATTI, Edgar Gil; ROCHA, Vanderson; SANDES, Alex Freire; RODRIGUES, Celso ArraisconferenceObject Comparison of Peripheral Blood Stem Cells (PBSC) to Bone Marrow (BM) for T-Replete HLA-Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide(2016) BASHEY, Asad; ZHANG, MeiJie; MCCURDY, Shannon R.; CIUREA, Stefan O.; MARTIN, Andrew St; ANASETTI, Claudio; ARGALL, Trevor; FASAN, Omotayo O.; GABALLA, Sameh; HAMADANI, Mehdi; MALKI, Monzr M. al; MUNSHI, Pashna N.; NAKAMURA, Ryotaro; O'DONNELL, Paul V.; PERALES, Miguel-Angel; RAJ, Kavita; ROCHA, Vanderson; ROMEE, Rizwan; ROWLEY, Scott D.; SALIT, Rachel; SOLH, Melhem; SOIFFER, Robert J.; WINGARD, John R.; WEISDORF, Daniel J.; HOROWITZ, Mary M.; FUCHS, Ephraim Joseph; EAPEN, Mary